We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Centers for Medicare & Medicaid Services (CMS) revealed two possible strategies last week for addressing future coverage decisions regarding implantable cardiac defibrillators (ICDs).
The Centers for Medicare & Medicaid Services (CMS) has revised the national coverage determination (NCD) framework for both single- and dual-chamber pacemakers.
The Centers for Medicare and Medicaid Services (CMS) has launched a series of coverage and payment initiatives to combat Medicare abuse related to power wheelchairs and power scooters.
The Centers for Medicare & Medicaid Services (CMS) has approved special pass-through payment rates for four ambulatory payment classifications (APCs) qualifying as new technologies under the outpatient prospective payment system (OPPS).
Electromagnetic therapy used for limited types of wound treatment will be covered by Medicare beginning July 1, the Centers for Medicare & Medicaid Services (CMS) has announced.
Assessing a product's marketability early in the development process is the key to successful product commercialization and achieving reimbursement, say medical device marketing experts Jennifer Murray and Victoria Hunsicker Sanko.
President Bush has selected FDA Commissioner Mark McClellan to be the next administrator of HHS' Centers for Medicare & Medicaid Services (CMS), the White House announced Feb. 20.
Devicemakers could benefit if FDA Commissioner Mark McClellan leaves the agency and takes over as head of the Centers for Medicare & Medicaid Services (CMS) because of his intimate knowledge of the industry, according to AdvaMed.
The Centers for Medicare & Medicaid Services (CMS) is implementing several changes to the national coverage determination (NCD) process called for under the landmark Medicare Rx Act, which was signed into law Dec. 8.